P716 Clinical significance of residual non-rectal inflammation in ulcerative colitis patients with clinical remission
ECCO'20 Vienna
2020
P717 Ustekinumab in Crohn’s disease: Real-world outcomes from the Sicilian Network for inflammatory bowel diseases (SN-IBD):–Preliminary results
ECCO'20 Vienna
2020
P718 Combination therapy of adalimumab with an immunomodulator is not more effective than adalimumab monotherapy in children with Crohn’s disease
ECCO'20 Vienna
2020
P719 Effectiveness and safety of ustekinumab induction therapy in ulcerative colitis: A GETAID real-world cohort study
ECCO'20 Vienna
2020
P720 Recurrent rectovaginal fistula in patients with Crohn’s disease: How can we improve the success rate of graciloplasty? A bi-centric European study in 30 patients
ECCO'20 Vienna
2020
P721 Early vedolizumab trough levels are associated with induction therapy outcome
ECCO'20 Vienna
2020
P722 Upadacitinib was not associated with anaemia in patients with moderately to severely active ulcerative colitis: Results from the U-ACHIEVE study
ECCO'20 Vienna
2020
P723 Therapeutic thresholds for golimumab serum concentrations during induction and maintenance: Results from the GO-LEVEL study
ECCO'20 Vienna
2020
P724 Delaying an infliximab infusion by more than 3 days is associated with a significant reduction in trough levels
ECCO'20 Vienna
2020
P725 Trends in biologic use prior to resective surgery for inflammatory bowel disease: A Canadian population-based study
ECCO'20 Vienna
2020
P726 Effectiveness of vedolizumab therapy in a real-world setting in Germany: First results of the VEDOibd study comparing vedolizumab to the use of other biologics
ECCO'20 Vienna
2020
P727 Small bowel capsule endoscopy impact on therapeutic decisions in established Crohn’s disease: Analysis of a real-world data
ECCO'20 Vienna
2020
P729 The SAPPHIRE registry: Safety of immunosuppression in a prospective cohort of inflammatory bowel disease patients with a HIstoRy of CancEr
ECCO'20 Vienna
2020
P730 Effectiveness and safety of endoscopic balloon dilation of colorectal strictures in Crohn’s disease
ECCO'20 Vienna
2020
P731 Biologics use in elderly patients with IBD: Experience in a UK secondary care setting
ECCO'20 Vienna
2020
P733 The influence of concomitant familial Mediterranean fewer on Crohn’s disease course: Data from an FMF endemic area
ECCO'20 Vienna
2020